Josh Canavan

Josh Canavan is the head of pharmacy at RazorMetrics.

Articles by Josh Canavan

Scientist analyzing biosimilars for quality and efficacy, drug comparison, pharmaceutical standards | © Photo18@desing - stock.adobe.com (952831370)

From Promise to Proof: The Shakeup in Today’s Biosimilar Market

May 19th 2026

Latest Updated Articles

Trending on Pharmaceutical Commerce

FDA Finalizes Guidance on Prescription Drug Companion Apps

FAQ: How Is AI Being Deployed in Pharma Supply Chains?

BioPharma Supply Chains of the Future: What to Know About Localization

PAXAFE’s Mark Talens: Supply Chain Teams Must Shift From Firefighters to Orchestrators

Where Cold Chain Expertise Gaps Put Advanced Therapies at Risk